Editorial: Assessing the Prognosis of Patients With HBV and ACLF-Comorbidities Matter. Authors' Reply

Aliment Pharmacol Ther. 2024 Nov 13. doi: 10.1111/apt.18392. Online ahead of print.
No abstract available

Publication types

  • Editorial